New Research: Multicenter review of a tadalafil suspension formulation for infants and children with pulmonary hypertension: A North American experience: Introduction Phosphodiesterase type 5 (PDE5) inhibitors, with sildenafil the earliest… https://t.co/0
RT @EversPD: Important large cohort experience of infants and young children using QDAY dosed tadalafil in place of TID sildenafil. Parent…
Important large cohort experience of infants and young children using QDAY dosed tadalafil in place of TID sildenafil. Parents of babies deserve the convenience as well? @PaulCritserMD @OHSUpicufellows @leahdowney https://t.co/m8Cd0OZhtI
#Great team work and amazing experience # Stollery Children's Hospital Pediatric PH program # Humbled! Multicenter Review of a Tadalafil Suspension Formulation in Infants and Children with Pulmonary Hypertension: A North American Experience https://t.co/yJ